Medi-Tech Insights

Growing prevalence of dental disorders, rising geriatric population, awareness on importance of oral health, and government support for adoption of Electronic Dental Records (EDRs) are driving the dental practice management software market.

The CMF Devices market growth is driven by growing volumes of CMF procedures and the rising adoption of patient specific implants.

The dental 3D printing market growth is driven by continual push to digitize dental practices, increasing dental diseases, and the growth in group practices.

The global biologics consulting services market is driven by the growing biopharmaceutical market, increasing R&D in advanced therapies like cell & gene, growing biologics regulatory approvals, and significant VC funding for biologics.

Favorable regulatory environment, accelerated use of telemedicine, growing focus on reducing the abuse of controlled substances, increasing adoption of EHR solutions are the key factors driving the growth of e-Prescribing market.

High investments in R&D, increasing usage of digital devices, development of novel products by market players, high cost involved in drug development, and rising demand for mobile health apps are the key factors driving the digital biomarkers market.

Rising preference for point-of-care (POC) testing services, government support to scale up production of IVD kits, growing incidence of cancer and infectious diseases are the key factors driving the Global IVD Contract Manufacturing Services Market.

The global CRO services market is driven by growing R&D spending, rising innovation in therapeutic areas like oncology, the need for cost-efficiency and faster time-to-market and rising complexity of drugs and clinical trials.

Advantages of nanopore sequencing such as high throughput & ultra-long reads, technological advancements in nanopore technologies, increasing prevalence of infectious diseases and rising investments are driving the nanopore sequencing market.

The global clinical trial supplies market is driven by growing R&D expenditure, increasing clinical trial complexity and regulatory requirements, robust Venture Capital activity in the Biotech sector and growth in clinical trials conducted.